Until FDA warning, thickener used in NICUs without trials

This article looks at how the practice of using a formula and milk thickener to treat infants with difficulty swallowing was adopted without reviews, leading to an FDA warning that it may cause necrotizing enterocolitis. The thickener used a food ingredient that did not need to be reviewed by the FDA since it was on the "generally recognized as safe" list.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA